
    
      Eligibility for participation of this study will be determined from demographic information,
      medical history, physical examination, electrocardiogram (ECG) and clinical laboratory tests
      within 4 weeks before study drug administration. Subjects suitable for this study will be
      admitted to the Clinical Trial Center of CHA Bundang Medical Center on the day before dosing
      (Day -1).

      From Day 1 to 5, Subjects will be dosed study drug (Pletaal SR Cap. 200 mg once a day or
      Cilostan CR Tab. 200mg once a day).

      Pharmacokinetic samplings will be done upto 24 hours after 1st study drug dosing and upto 72
      hours after 5th study drug dosing.

      After 9 days of washout period (Day 15), Subjects will be dosed study drug and
      pharmacokinetic samplings will be done by crossover manner.
    
  